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Abstract 
Background: Claudin and occludin are the important tight junctions protein in human. The downregulation or 
upregulation of claudins and occludin might have a role in cancer development. The objective of this study was to 
investigate the expression of claudin-5, claudin-7 and occludin in oral squamous cell carcinoma (OSCC) and their 
relationships with the prognostically-related clinico-pathologic features.
Material and Methods: Standard indirect immunohistochemical technique using anti-claudin-5, anti-claudin-7 and 
anti-occludin was performed in formalin-fixed paraffin-embedded tissue sections of 66 OSCC samples from Facul-
ty of Dentistry, Chulalongkorn University. The positive cases were divided into 2 groups, the low expression group 
(cases with less than 50% of positive cancer cells) and the high expression group for statistical analysis. Categorical 
analysis of the clinico-pathologic parameters together with univariate analysis using the Kaplan-Meier method and 
the log rank test were performed. 
Results: There were 22 male and 23 female patients enrolled in this study, with a mean age of 65.82+12.10 years. 
The claudin-5 immunoreactivity was observed in 26.6% of cases. The positive immunoreactivity of claudin-7 is 
more noted (93.3%).  Only 4 cases showed occludin immunoreactivity (8.9%) and all of them show positivity less 
than 25% of cancer cells. Only loss of claudin-7 expression  was associated with the high pathologic grade, advan-
ced TNM staging,  large tumor size, the presence of microscopic perineural, vascular invasions and regional lymph 
node involvement. There is a tendency towards the association of the higher claudin-7 expression and a longer 
survival time (P=0.012).
Conclusions: The results showed expression of claudin-5, claudin-7 and low expression of occludin in OSCC. Only 
claudin-7 expression showed impact on clinic-pathological parameter of OSCC.
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Introduction
Intercellular junctions are important structures for phy-
siologic functions of the cells. Tight junctions (TJs), one 
of the intercellular junctions, play a main role for signa-
ling cascades that control cell growth and differentiation 
(1). TJs are thought to play critical roles in the neoplastic 
process from their roles in extracellular and  intracellular 
signaling pathways (2). 
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TJ comprise of three major transmembrane proteins, 
namely claudins, occludin, and junctional adhesion mo-
lecules (3). Currently, at least 24 different members of 
the claudin family are known in humans. They act as a 
barriers for cellular ionic selectivity seen in epithelium. 
Expression of claudins may vary in different cells and 
tissues of the body. For example, claudin 2 is found in 
murine liver and kidney (4) but not in lung tissue while 
claudin 4 is found in murine lung and kidney but not in 
the liver (5). 
Abnormalities of TJ permeability allow increased diffu-
sion of factors that promote tumor growth. Moreover, 
changes in TJs have been noted as an early event in tu-
mor metastasis (6). Downregulation or upregulation of 
claudins might have a role in cancer development. The 
altered expression of some claudins has also been found 
in many human carcinomas such as those of the oral (7), 
breast (8), ovary (9), and stomach (10). 
Claudin expression has been also shown to have prog-
nostic value in many tumors. Loss or gain in claudin 
expression has been associated with biologic behavior 
in some tumor types (11-13). Reduced expression of 
claudin will result in cell to cell adhesiveness break-
down which can promote cancer invasion and metasta-
sis.  However, the mechanism by which overexpression 
of claudins may contribute to tumor progression and 
aggressiveness is less clear. It has been suggested that 
a possible mechanism for this is that up-regulation and/
or aberrant tissue expression of claudins may directly 
interfere with TJ formation and function and thereby 
contribute to neoplasia .  Nevertheless, relatively few 
studies have described the expression of claudins or 
their relationship with tumor activity or behavior in oral 
squamous cell carcinoma (OSCC) (3,8,13). 
Occludin expression decreased progressively in parallel 
with the increase in carcinoma grade, and the decreased 
occludin expression correlated with myometrial inva-
sion and lymph node metastasis in endometrial carcino-
ma (14). About squamous cell carcinoma, there are only 
few studies showing expression or clinical correlation of 
occludin staining (13,15). 
No study, to the best of our knowledge shows the as-
sociation of claudin-5, claudin-7 together with occludin 
expression in oral squamous cell carcinoma (OSCC) 
and their clinic-pathological prognostic factors. There-
fore, the objective of this study was to investigate the 
expression of these two members of the claudin family 
and occludin in OSCC and their relationships with the 
prognostically-related clinical-pathologic features.
Material and Methods 
Forty five of oral squamous cell carcinoma (OSCC), 
from various sites in the oral cavity in the archive of 
biopsy specimen at the Department of Oral Pathology, 
Faculty of Dentistry, Chulalongkorn University since 
2006-2012 were recruited for the study. Re-examination 
of histopathologic slides were examined under light mi-
croscope by two oral pathologists, both to confirm the 
diagnosis and grading of tumor. Briefly, the tissue sec-
tions were cut at 4-µm thick, initially stained with hema-
toxylin and eosin (H&E). The patients’ history were re-
viewed. Other clinical data such as patients age, gender, 
lymph node status and recurrent were  collected. Cases 
were excluded if the specimen included any other asso-
ciated pathology (e.g. chronic fungal, bacterial infection 
or other tumors).
For immunohistochemical study, procedure was performed 
with Leica Microsystems Bond-Max Autostainer System. 
Paraffin-embedded blocks from the tumor with adjacent 
areas and control tissue specimens were 5-µm thick then 
deparaffinised with Bond Dewax Solution. The antigen re-
trieval was performed by incubating slides with the Bond 
Epitope Retrieval Solution 2 for 30 minutes at 95oC for 
claudin-5 and 7 staining. For occludin staining, the section 
was treated with pronase (Tris-HCl, pH 7.6) for 8 minutes 
at 37°C and then cooled for 3 minutes at 4°C.
The primary antibodies used were the polyclonal anti-
claudin-5 (1:200 dilution), monoclonal anti-claudin-7 
(1:500 dilution) antibodies (Invitrogen, Camarillo, CA) 
and  polyclonal anti-occludin antibody (1:50 dilution). 
A 3-step indirect immunoperoxidase technique was per-
formed using the Bond Polymer Refine Detection kit 
(Leica Microsystems). The primary antibodies were in-
cubated for 50 minutes at room temperature, then 3% 
hydrogen peroxide was applied for 5 minutes, followed 
by 12 minutes incubations with the Post Primary Poly-
mer and the Polymer Poly-HRP IgG, respectively. The 
sections were reacted with diaminobenzidine chromo-
gen for 3 minutes and counterstained with hematoxylin. 
The Bond Wash Solution was used to rinse between each 
step. The colon mucosa were used as positive controls. 
Negative control staining was carried out by substituting 
nonimmune rabbit or mouse serum and phosphate-bu-
ffered saline (PBS) for the primary antibodies.
-Immunostaining assessment and statistical analysis
The immunohistochemical assessment was performed 
and agreed upon by two pathologists who were blinded 
to all patient clinical and follow-up data. The positive 
immunoreactivity localized at the cell membrane of neo-
plastic cells was evaluated. Overall, the percentage of 
positive neoplastic cells was semi-quantitatively asses-
sed and categorized into one of the following groups: 0 
= no positive cells; 1+ = positive cells detected less than 
25% of tumor; 2+ = positive cells detected between 26-
50% of tumor; 3+ = positive cells detected between 51-
75% of tumor and 4+ = positive cells detected more than 
75%.  The expressions of claudin-5, claudin-7 and oc-
cludin were further classified as low immunoreactivity 
(groups 0, 1 and 2) and high immunoreactivity (groups 3 
and 4) for statistical analysis.
J Clin Exp Dent-AHEAD OF PRINT                                                                                                                                             Claudin and occludin in oral squamous cell carcinoma
E3
The results were statistically analysed using the IBM 
SPSS Statistics version 21 (IBM Corporation, NY) for 
Windows. The continuous variables were expressed as 
means + standard deviation (SD). Categorical analysis 
of the clinico-pathologic parameters and the claudin-5, 
claudin-7 and occludin expressions were performed 
using either the Pearson’s chi-square test or the Fisher’s 
exact test, as appropriate. A P-value less than 0.05 was 
considered statistically significant.
For analytical statistical analysis, the clinico-pathologic 
features were grouped as following: age below or above 
65 year-old (the mean age of patients); tumor size (T1-
T2 and T2-T4); early TNM stage (I, II) or late TNM sta-
ges (III, IV); microscopically well differentiated or mo-
derately/poorly differentiated; the presence of perineural 
invasion and vascular invasion, local recurrence, regio-
Clinical and pathologic variables Number of patient(N)
Sex Male
Female
22(48.9%)
23(51.1%)
Age (years) Mean +- SD (65.82 +-12.10)
Range (44-86)
Site Gingiva
Floor of mouth
Tongue
Buccal mucosa
Alveolar mucosa
Hard palate
17(37.8%)
8(17.8%)
7(15.6%)
6(13.3%)
4(8.9%)
3(6.7%)
T stage T1
T2
T3
T4
24(53.3%)
11(24.4%)
5(11.1%)
5(11.1%)
N stage N0
N1
N2
N3
21(46.7%)
13(28.9%)
7(15.6%)
4(8.9%)
Distant 
metastasis
Absence
Presence
35(77.8%)
10(22.2%)
Recurrence Absence
Presence
35(77.8%)
10(22.2%)
Pathologic 
grade
Well differentiated
 Moderately differentiated
Poorly differentiated
24(53.3%)
15(33.3%)
6(13.3%)
Perineural 
invasion
Absence
Presence
28(62.2%)
17(37.8%)
Vascular 
invasion
Absence
Presence
26(57.8%)
19(42.2%)
TNM staging Stage I
Stage II
Stage III
Stage IV
18(40.0%)
6(13.3%)
7(15.6%)
14(31.1%)
nal lymph node involvement and distant metastasis.
The disease-specific survival was determined as the time 
following surgical operation to the time of patient died 
of cancer. Univariate analysis using the Kaplan-Meier 
method and the log rank test were used to analyze the 
significant differences between groups.
The study was ethically approved by ethical committee, 
Faculty of Dentistry, Chulalongkorn University, Thai-
land. This study was conducted in strict accordance with 
the ethical principles of the Declaration of Helsinki.
Results
-Patient characteristics
Clinical and pathological detail of the patients are shown 
in table 1. There were 22 male and 23 female patients 
enrolled in this study, with a mean age of 65.82+12.10 
Table 1. Clinical and pathological detail of the patients.
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years (range= 44-86 years). Most of lesions were lo-
cated on gingiva (37.8%), followed by floor of mouth 
(17.8%), tongue (15.6%) and buccal mucosa (13.3%). 
Recurrence was found in ten patients (22.2%). Twenty-
four patients (53.3%) had regional lymph node invol-
vement, and 2 of them had distant metastasis (4.4%). 
The majority of patients were classified as TNM stage I 
(40.0%), followed by stage IV (31.1%). 53.3% of cases 
was well-differentiated squamous cell carcinoma, fo-
llowed by moderately differentiated (33.3%) and poorly 
differentiated (13.3%). Perineural invasion was found 
in 17 patients (37.8%) while perivascular invasion was 
found in 19 patients (42.2%).
-Expression of claudin-5 and claudin-7 in OSCC
Immunohistochemical staining of OSCC cells was 
shown in figures 1,2,3 and table 2. The tumor cells in 
Fig. 1. Representative photomicrographs of mild staining of claudin-5 (1A) and intense staining of claudin-5 (1B).
Fig. 2. Representative photomicrographs of plasma membrane staining of claudin-7 (2A) and intense plasma membrane and 
cytoplasmic staining of claudin-7 (2B).
the central area shows intense staining than cells in peri-
pheral area. All positive cells for claudin-5 and occludin 
show cell membrane staining pattern except claudin-7 
which also shows cytoplasmic staining. The claudin-5 
immunoreactivity was observed in 26.6% of cases. The 
majority of them (17.8%)  showed positive staining less 
than 25% of cancer cells (level 1+; 17.8%), followed by 
the staining in 51-75% of cells (level 3+; 6.7%) (Fig. 
1). The positive immunoreactivity of claudin-7 is more 
noted (93.3%).  Twenty-five cases (55.5%) showed clau-
din-7 positivity more than 50% of cancer cells in which 
20 cases (44.4%) showed positivity more than 75% (Fig. 
2).
While only 4 cases showed occludin immunoreactivity 
(8.9%) and all of them show positivity less than 25% of 
cancer cells (Fig. 3). 
-Relationships between the claudin-5 and claudin-7 ex-
pressions and the clinico-pathologic features
The cases positive to claudin-5 and claudin-7 were di-
vided into 2 groups, the low expression group (cases 
with less than 50% of positive cancer cells) and the high 
expression group (cases with more than 50% of positi-
ve cancer cells) for clinicopathological correlation. No 
significant found between occludin expression and cli-
nicopathological parameters due to low number of cases 
positive to occludin. 
Relationship between claudin-5 and claudin-7 expres-
sion and clinico-pathologic features of OSCC patients 
are shown in table 3. No sex or age difference was obser-
ved between the two groups. Significantly, loss of clau-
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Fig. 3. Representative photomicrographs of negative staining of occludin (3A) and mild staining of occludin (3B).
Staining
Marker
IHC staining
0 1+ 2+ 3+ 4+
Claudin 5 33(77.3%) 8(17.8%) 1(2.2%) 3(6.7%) 0(0%)
Claudin 7 3(6.7%) 2(4.4%) 15(33.3%) 5(11.1%) 20(44.4%)
Occludin 41(91.1%) 4(8.9%) 0(0%) 0(0%) 0(0%)
Table 2. Immunohistochemical staining of OSCC cells.
Clinico pathologic  parameter Claudin 5 expression Claudin 7 expression
Low High P value Low High P value
Sex Male
Female
21
21
1
2
1.02 9
11
13
12
0.641
Age (years) <65
>65
13
29
1
2
1.06 5
15
9
16
0.428
TNM staging Stage1-2
Stage3-4
23
19
1
2
0.592 3
17
21
4
0
Tumor size T1-T2
T3-T4
33
9
2
1
0.539 12
8
23
2
0.014
Lymph node 
involvement
Absence
Presence
21
21
0
3
0.236 4
16
17
8
0.001
Distant 
metastasis
Absence
Presence
41
1
2
1
0.13 18
2
25
0
0.192
Recurrence Absence
Presence
9
33
0
3
1 6
14
3
22
0.157
Pathologic 
grade
Well differentiated 22 2 1 7 17 0.027
Moderately/poorly 
differentiated
20 1 13 8
Perineural 
invasion
Absence
Presence
27
15
1
2
0.547 7
13
21
4
0.01
Vascular 
invasion
Absence
Presence
24
18
2
1
1 8
12
18
7
0.031
Table 3. Categorical analysis of the clinico-pathologic parameters and the claudin-5, claudin-7 expressions using either the Pearson’s chi-square 
test or the Fisher’s exact test, as appropriate.
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din-7 expression was associated with the high patholo-
gic grade (P=0.027), advanced TNM staging (P=0.00), 
large tumor size (P=0.01), the presence of microscopic 
perineural (P=0.01) and vascular (P=0.031) invasions 
and regional lymph node involvement (P=0.001). 
-Survival analysis
The follow up period ranged from 8 to 119 months 
(median=38 months). Seventeen patients died of OSCC 
at the end of the follow-up period.  Two patients died 
of other causes and the remaining 26 patients were ali-
ve with no disease. The advanced clinical staging was 
strongly correlated with the poor overall patient survival 
(P=0.01). Regarding claudin expressions, the univariate 
survival analysis showed that claudin-5 expression has no 
statistically significant association with cancer-specific 
survival of patients (P=0.131) while there is a tendency 
towards the association of the higher claudin-7 expression 
and a longer survival time (P=0.012) (Fig. 4).
Fig. 4. Kaplan–Meier curve of OSCC patients with low (less than 50 % positivity) versus high (more than 
50 % positivity) expression of claudin-7 (P = 0.012)
Discussion
There are several studies demonstrated expression of di-
fferent tight junction proteins in a variety of human can-
cers (7,16). Among these tight proteins junction, claudin 
and occludin are main important molecules . 
The dissociation of cancer cells from the primary cancer 
nests is a crucial step for cancer progression and me-
tastasis. Loss of cell-cell adhesiveness may trigger the 
release of cancer cells from the primary cancer nests and 
confer invasive properties on a tumor (2).
Claudin 7 expression was found to be down-regulated in 
ductal carcinoma of the breast cancer (17), cervical can-
cer compared with CIN/CIS lesions (18) , and squamous 
cell carcinoma of esophagus (19). In contrary, increased 
expression of claudin 7  has been also reported in gastric 
adenocarcinomas (20) invasive carcinoma of the uterine 
cervix (21). The results for the discrepancy are still not 
well understood. 
In our study, we reported the potential role of claudin-7 
in clinico-pathological correlation of OSCC. Loss of 
claudin-7 expression was associated with the high pa-
thologic grade advanced TNM staging, large tumor size, 
the presence of microscopic perineural and vascular in-
vasions and regional lymph node involvement. These 
findings are consistent with previous reports of Melchers 
that  lack of claudin-7 expression in the tumor center 
may be used to identify patients with increased risk for 
regional recurrence of OSCC (22). The study of Usami 
(19) in esophageal cancer also shows that expression of 
claudin-7 at the invasive front is statistically correlated 
with the depth of invasion, stage, lymphatic vessel inva-
sion, and lymph node metastasis.
Also, higher claudin-7 expression in our study relates 
with longer survival time which seems that claudin 7 ex-
pression may be a favorable prognostic significance in 
patients with OSCC like studies in many other centers 
by (11) (13,23). The study in hepatocellular carcinoma 
by Bouchagier also shows that  down-regulation of clau-
din-7 are positive prognostic markers and are associated 
with good outcome and increased survival rates (24). 
This prognostic implication was not shown in occludin 
or claudin 5.  
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Nevertheless, in some studies high claudin-7 expression 
was significantly associated with a poorer prognosis of 
the patients with gastric cancer (20) which did not co-
rrespond with  our study. Also the study in urothelial 
carcinoma shows no clinicopathological correlation of 
claudin-7 expression (25).
Claudin-5 expression is revealed to correlated with lym-
ph node metastasis in esophageal carcinoma (12) which 
is not shown in our study.  Down-regulated claudin-5 ex-
pression in tumor vessels may serve as a potential mar-
ker for poor prognosis in hepatocellular carcinoma (26) 
while  increased claudin-5 expression is associated with 
aggressive behavior in serous ovarian adenocarcinoma 
(27). The reason why expression of claudin-5 in many 
cancer is different is still a controversial issue. 
Occludin is believed to be not essential for TJ formation 
and function but may play a role in cellular signaling. 
The expression of occludin in our study is mostly nega-
tive which corresponds with study in tongue squamous 
cell carcinoma (13). While study in hepatocellular carci-
noma (24), urothelial carcinoma show occludin expres-
sion without clinic-pathological impact (25). 
Loss of claudin expression of the cell can directly pro-
mote the neoplastic process because the TJs were destro-
yed. Moreover,  lack of claudin-7 or less tight junctions 
consequently increased availability of nutrients and li-
gands (28). This would lead to increased proliferation, in 
agreement with  study of Ding showing the increase pro-
liferation of epithelial cells in the intestine of claudin-7 
deficient mice (29). 
Conversely, there are some experiments showing that 
overexpression of some claudins  may  interfere with 
the functional tight junctions, instead, overexpression of 
them can reversely  increased tumor  invasion.  The me-
chanism by which overexpression of claudin may con-
tribute to tumor progression is less understood. Study 
by Lioni in in vitro knockdown of claudin-7 resulted in 
increased invasion in esophageal SCC (30). Other me-
chanism proposed may involve   increased matrix meta-
lloproteinase 2 activity by signaling cascade of claudin. 
Conclusions
Based on this study, there are claudin-5 and 7 expression 
in OSCC. Only claudin-7 expression might be useful for 
predicting OSCC behavior and prognosis of the patients.
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